微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | -4.93% | -293.33% | -79.93% | 127/159 | 1.21% | 兴齐眼药 | 32.91% | 行业排名> |
| 2025-06-30 | -2.74% | -554.39% | 30.28% | 123/159 | 0.26% | 翰宇药业 | 18.95% | 行业排名> |
| 2025-03-31 | -3.93% | -1455.17% | -236.93% | 136/159 | -0.37% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-12-31 | 2.87% | 151.53% | 12.55% | 80/159 | -9.52% | 百利天恒 | 181.27% | 行业排名> |
| 2024-09-30 | 2.55% | 325% | 322.89% | 91/159 | 4.23% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 0.6% | 438.39% | 107.93% | 107/159 | 2.66% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 0.29% | -81.29% | 105.21% | 110/159 | 2.32% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | -5.57% | -5.29% | -1028.33% | 119/159 | -1.03% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 0.6% | 123.44% | 435.71% | 112/159 | 2.34% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 0.11% | 107.97% | -92.77% | 113/159 | 1.46% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 1.55% | 278.05% | 129.3% | 70/159 | 1.37% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | -5.29% | -11.6% | -106.64% | 118/159 | 0.67% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | -2.56% | -196.6% | -82.08% | 118/159 | 2.8% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | -1.41% | 5% | -442.93% | 119/159 | 2.16% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 0.41% | -91.82% | 108.65% | 108/159 | 1.57% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | -4.74% | 38.84% | -278.87% | 121/159 | 0.75% | 人福医药 | 6.82% | 行业排名> |
| 2021-09-30 | 2.65% | 234.52% | 279.05% | 98/159 | 4.43% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | -1.48% | -7.25% | -129.54% | 120/159 | 2.94% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 5.01% | 1465.63% | 164.65% | 13/159 | 2.49% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | -7.75% | -157.48% | -293.4% | 118/159 | 3.58% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | -1.97% | -185.65% | -42.75% | 101/159 | 3.03% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | -1.38% | -6800% | -531.25% | 110/159 | 4.19% | 河化股份 | 45.32% | 行业排名> |
| 2020-03-31 | 0.32% | 3.23% | 110.63% | 81/159 | 2.19% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | -3.01% | 82.36% | -230.87% | 120/159 | 2.53% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 2.3% | -41.92% | 11600% | 94/159 | 7.48% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | -0.02% | -101.63% | -106.45% | 108/159 | 4.96% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 0.31% | -56.34% | 101.82% | 97/159 | 2.41% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | -17.06% | -924.15% | -530.81% | 129/159 | 6.99% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 3.96% | 14.45% | 221.95% | 78/159 | 7.18% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | 1.23% | -32.04% | 73.24% | 92/159 | 4.6% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 0.71% | -16.47% | -65.7% | 85/159 | 2.54% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 2.07% | -28.62% | -40.17% | 107/159 | 9.61% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 3.46% | -4.68% | 91.16% | 71/159 | 8.29% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | 1.81% | 724.14% | 112.94% | 84/159 | 5.58% | 丽珠集团 | 49.43% | 行业排名> |
| 2017-03-31 | 0.85% | 237.1% | -70.69% | 63/159 | 2.09% | 河化股份 | 54.24% | 行业排名> |
| 2016-12-31 | 2.9% | -7.94% | -20.11% | 92/159 | 6.19% | 华东医药 | 7.2% | 行业排名> |
| 2016-09-30 | 3.63% | 78.82% | 1351.72% | 64/159 | 5.61% | 南新制药 | 81.7% | 行业排名> |
| 2016-06-30 | -0.29% | -124.58% | 53.23% | 83/159 | 3.48% | 德展健康 | 29.5% | 行业排名> |
| 2016-03-31 | -0.62% | -12.73% | -119.68% | 77/159 | 2.65% | 贝达药业 | 16.78% | 行业排名> |
| 2015-12-31 | 3.15% | 17.98% | 55.17% | 80/159 | 11.27% | 河化股份 | 19.29% | 行业排名> |
| 2015-09-30 | 2.03% | -13.25% | 72.03% | 63/159 | 7.22% | 一品红 | 58.17% | 行业排名> |
| 2015-06-30 | 1.18% | -9.23% | 314.55% | 64/159 | 4.87% | 华东医药 | 36.97% | 行业排名> |
| 2015-03-31 | -0.55% | -600% | -120.6% | 69/159 | 2.41% | 华东医药 | 26.63% | 行业排名> |